Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
stroke
Pharma
FDA approves Agepha’s version of colchicine for heart disease
Agepha Pharma of Slovakia has gained an FDA approval for Lodoco, which becomes the first drug to target cardiovascular inflammation.
Kevin Dunleavy
Jun 20, 2023 8:10am
Nasal delivery gets antibody to rodent brains to treat stroke
Jan 24, 2023 6:40am
J&J-Legend, Junshi, Vir-WuXi and more—Fierce Pharma Asia
May 27, 2022 9:53am
ACC: Lexicon's sotagliflozin can cut stroke, heart attack
Apr 2, 2022 3:37pm
AstraZeneca's Brilinta wins FDA nod for stroke patients
Nov 6, 2020 11:18am
AZ's Brilinta aims for label boost with stroke priority review
Jul 16, 2020 11:21am
